What are the risks and side effects of starting TRT in your 30s?

Short answer: testosterone replacement therapy (TRT) can help with low-T symptoms (libido, energy, muscle) but it also carries important short- and long-term risks — especially for men in their 30s who may still want biological children. Before starting, discuss risks, baseline testing and follow-up with an endocrinologist or urologist.

Main risks and side effects

• Suppressed fertility / reduced sperm count: exogenous testosterone suppresses the hypothalamic–pituitary–gonadal (HPG) axis → lower LH/FSH → reduced spermatogenesis. This can be profound and sometimes prolonged. Men who want children should assume TRT may make them temporarily (or less commonly, permanently) infertile.
• Testicular atrophy: smaller testes due to reduced endogenous testosterone production.
• Erythrocytosis (high red blood cell count): raised hematocrit increases blood viscosity and can raise risk of clots/stroke; common reason for dose adjustment or periodic phlebotomy.
• Cardiovascular concerns: evidence is mixed. Some studies suggest increased risk of events in men with preexisting heart disease; others show neutral or beneficial effects. Individual CV risk factors matter.
• Prostate effects: TRT can raise PSA and may worsen lower urinary tract symptoms; TRT is contraindicated in known prostate cancer. Baseline PSA and prostate evaluation are recommended.
• Acne, oily skin, hair loss (male-pattern baldness) — dose-dependent.
• Gynecomastia (breast enlargement) from aromatization to estrogen in some men.
• Mood/behavior changes: improved mood and libido are common, but some people develop irritability, aggression or mood swings.
• Fluid retention and worsening sleep apnea: TRT can exacerbate obstructive sleep apnea or cause edema.
• Liver effects: more of a concern with older oral androgenic steroids; modern transdermal and injectable testosterone have low hepatic toxicity. Oral alkylated androgens (not standard TRT) are hepatotoxic.
• Injection/administration problems: injection-site pain, gel transfer to partners/children (AndroGel/Testim), patch irritation (Androderm).
• Dependency/suppression of natural hormone production: long-term TRT usually requires ongoing therapy because endogenous production may not fully recover.

Fertility-specific options and considerations

• If you plan children, talk to a reproductive urologist before starting TRT.
• Alternatives that increase testosterone without shutting down spermatogenesis in many men: clomiphene citrate (Clomid) or tamoxifen (Nolvadex) — they stimulate the HPG axis and often preserve fertility.
• Human chorionic gonadotropin (hCG; brands like Pregnyl or Ovidrel for off-label use) can preserve testicular function and sperm while on testosterone or can be used instead of testosterone.
• Sperm banking (cryopreservation) before starting TRT is a simple precaution if you might want to father children later.

Monitoring and baseline tests

• Before starting: total and free testosterone (morning), LH, FSH, prolactin (if indicated), CBC/hematocrit, PSA, lipid panel, fasting glucose/A1c, liver function tests. Consider baseline semen analysis if fertility matters.
• After starting: check testosterone and hematocrit at ~3 months, recheck CBC, PSA and lipids as recommended (commonly every 3–6 months initially, then 6–12 months). Adjust dose if hematocrit rises >54% or symptoms/problems occur.
• Use reliable labs such as Quest Diagnostics or LabCorp for testing and keep records.

Forms of TRT and practical differences (examples)

• Topical gels: AndroGel, Testim, Fortesta — avoid transfer to others; steady daily dosing.
• Transdermal patch: Androderm — skin irritation is common.
• Injectable: Depo-Testosterone (testosterone cypionate), Delatestryl (enanthate) — injections every 1–2 weeks can cause trough/peak swings; many prefer biweekly or weekly smaller doses.
• Long‑acting injection: Nebido (testosterone undecanoate) — fewer injections (every 10–14 weeks) and more stable levels in many men.
• Pellets: Testopel — implanted every few months; procedure-related issues possible.
• If fertility preservation is a goal, consider Clomid (clomiphene citrate) or using hCG (Pregnyl/Ovidrel) under specialist supervision.

Who should NOT start TRT (contraindications / caution)

• Known or suspected prostate or breast cancer.
• Hematocrit above normal / untreated polycythemia.
• Uncontrolled severe heart failure, uncontrolled sleep apnea, or high cardiovascular risk without specialist input.
• Men who strongly desire biological children without fertility-preserving strategies.

Practical next steps

1. Get confirmatory morning testosterone levels (at least two), plus LH/FSH and fertility counseling if you want kids.
2. Talk with an endocrinologist or urologist (or reproductive urologist if fertility concerns). If you prefer telemedicine, companies such as Roman or Hims offer TRT services but make sure they provide appropriate baseline testing and specialist referrals.
3. If you start TRT, arrange the baseline tests and a monitoring schedule (testosterone, hematocrit, PSA, lipids, LFTs).
4. If fertility matters: consider sperm banking and discuss Clomid or hCG-based strategies with a specialist before exogenous testosterone.

If you want, tell me:

• Are you considering TRT for symptoms, or have you already had low lab values?
• Do you want biological children in future? I can suggest a testing and discussion checklist tailored to your situation.